United States: 21st Century Cures Act – Provisions Relating To Reimbursement & Fraud And Abuse

On December 13, 2016, President Obama signed into law the 21st Century Cures Act (the Act), just days after it passed in the U.S. House of Representatives and Senate. With an overarching goal of advancing biomedical innovation, the Act makes numerous changes to laws that govern Food and Drug Administration (FDA) programs, clinical research regulations, and Medicare coverage and reimbursement rules.

To see Ropes & Gray's analysis of key provisions of the Act, please click on the hyperlinks below:

Partners in Ropes & Gray's FDA Regulatory practice have also recorded a podcast to discuss some key implications of the Act for biopharmaceutical and medical device manufacturers. Click here to listen to the podcast.

This Alert notes key changes to the Medicare and Medicaid programs, including changes to coverage and reimbursement rules affecting hospitals, ambulatory surgery centers, DME suppliers, and other providers. It also highlights a change to the Civil Monetary Penalties Law providing for penalties in cases of fraud involving HHS grants, contracts, or other agreements.

Greater Transparency of Local Coverage Determinations [Section 4010].1

Effective six months after enactment, the Act requires each Medicare administrative contractor that develops a local coverage determination to publish the following information on the contractor's website and on the Medicare website: (i) the determination in its entirety; (ii) where and when the proposed determination was first made public; (iii) hyperlinks to the proposed determination and responses to comments submitted; (iv) a summary of the evidence considered, along with a list of the sources; and (v) an explanation of the rationale supporting the determination.

Medicare Site-of-Service Price Transparency [Section 4012].

In order to facilitate price transparency of Medicare payment for hospital outpatient and ASC items and services, the Act requires HHS to make available, via a public searchable website, the Medicare estimated payment and beneficiary liability amounts for each item or service. The Act also provides a formula for calculating estimated beneficiary liability. This is expected to benefit ASCs, which generally provide services at a lower cost.

Medicaid Reimbursement to States for DME [Section 5002].

Effective January 1, 2018, the Act limits the amount of federal Medicaid reimbursement to states for durable medical equipment (DME), prosthetics, orthotics and supplies sold pursuant to a Medicaid fee schedule to the Medicare reimbursement rates. This section effectively eliminates federal financial participation for state Medicaid DME fee schedule payments that exceed the amount Medicare would have paid for the item, including in states that have launched competitive acquisition programs.

Reducing Overpayments of Infusion Drugs [Section 5004].

The Act changes the reimbursement methodology for infusion drugs furnished through an item of DME to the methodology used for the majority of physician-administered drugs: Average Sales Price (ASP) plus six percent. The Act also removes infusion drugs furnished through DME from competitive acquisition areas designated by the Secretary. This pricing structure is intended to reflect actual transaction prices in an attempt to remedy the over- and underpayment of certain drugs.

Allowing Physical Therapists to Utilize Locum Tenens Arrangements [Section 16006].

The Act allows physical therapists furnishing outpatient physical therapy services in certain underserved areas to use locum tenens arrangements, in the same manner as such arrangements apply to physicians.

Continuing Medicare Payment under HOPD Prospective Payment System for Services Furnished by Mid-build Off-campus Outpatient Departments of Providers [Section 16001].

Under Section 603 of the Bipartisan Budget Act of 2015 and implementing regulations issued by HHS in November 2016, most new hospital off-campus provider-based departments (HOPDs)—i.e., those that began furnishing services on or after the date of enactment of the Bipartisan Budget Act, or November 2, 2015—would be subject to payment reforms that provide for Medicare reimbursement under a modified fee schedule rather than the more favorable Hospital Outpatient Prospective Payment System (OPPS). In response to complaints from hospitals that had undertaken significant capital projects for HOPDs with the expectation of Medicare payments under the more favorable OPPS, the Act provides an exception for HOPDs defined as "mid-build" prior to November 2, 2015. The Act defines "mid-build" as a provider that had a binding written agreement with an outside, unrelated party for the actual construction of the HOPD. To qualify, each HOPD would submit a certification from the CEO/COO that it meets the "mid-build" requirements and an attestation that it is provider-based. The attestation would be subject to audit by the HHS Secretary. Qualifying HOPDs would receive the full OPPS payment rate beginning in 2018 rather than the lower physician fee schedule or ambulatory surgical center payments required under the Bipartisan Budget Act of 2015.

Penalties for Violations of Grants, Contracts and Other Agreements [Section 5003].

The Act adds several new violations to the list for which penalties are available under the Civil Monetary Penalties law. The newly added violations include: misrepresentations of "specified claims" under an HHS grant or contract; misrepresentations in a document required to receive or retain funds under an HHS grant or contract; misrepresenting a material "obligation" to transmit funds under an HHS grant; and failing, upon reasonable request, to grant timely access for audits or other statutory functions involving such grants or contracts.


1. Cited sections refer to the relevant provisions in the Act.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.